We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 16 of 209 for:    Recruiting, Not yet recruiting, Available Studies | "Cystic Fibrosis"

Transfer Impedance in Cystic Fibrosis (Ztr)

This study is currently recruiting participants.
Verified July 2017 by Thomas Martin, Boston Children's Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT00743158
First Posted: August 28, 2008
Last Update Posted: August 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Thomas Martin, Boston Children's Hospital
  Purpose
This study aims to determine whether respiratory system transfer impedance (Ztr) may fill an important clinical function by providing a reproducible, valid, and sensitive measure of airway obstruction in people with CF.

Condition
Cystic Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Transfer Impedance in Cystic Fibrosis (Ztr)

Resource links provided by NLM:


Further study details as provided by Thomas Martin, Boston Children's Hospital:

Estimated Enrollment: 40
Study Start Date: August 2008
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   2 Years to 25 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Cystic Fibrosis Patients
Criteria

Inclusion Criteria:

  • Between the ages of 2 to 25 Confirmed diagnosis of Cystic Fibrosis

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00743158


Locations
United States, Massachusetts
Childrens Hospital, Boston Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lamia Momen, BA    617-355-6665    lamia.momen@childrens.harvard.edu   
Principal Investigator: Thomas R Martin, MD         
Sponsors and Collaborators
Boston Children’s Hospital
  More Information

Responsible Party: Thomas Martin, Assistant Professor of Pediatrics, Boston Children's Hospital
ClinicalTrials.gov Identifier: NCT00743158     History of Changes
Other Study ID Numbers: X08-01-0060
First Submitted: August 27, 2008
First Posted: August 28, 2008
Last Update Posted: August 2, 2017
Last Verified: July 2017

Keywords provided by Thomas Martin, Boston Children's Hospital:
ztr
transfer impedance
cystic fibrosis
pulmonary function test
pft

Additional relevant MeSH terms:
Fibrosis
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases